Immunoglobulinâlike transcript 2 blockade restores antitumor immune responses in glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15575
Abstract: Glioblastoma stands as the most frequent primary brain tumor. Despite the multimodal therapy for glioblastoma patients, the survival rate is very low, highlighting the need for novel therapies that improve patient outcomes. Immune checkpoint blockade… read more here.
Keywords: responses glioblastoma; transcript blockade; blockade; like transcript ... See more keywords